These results may help the development of interventions tailored to APOE 4 carriers, especially women carriers, because women with APOE 4 allele are believed to be more likely to develop AD than their male counterparts due to greater hypometabolism and brain atrophy [30]. The gene discussed is APOE; the disease is Brain atrophy.